Loading…
Global agriculture company selling seeds (Pioneer brand) and crop-protection chemicals to farmers, spun off from DowDuPont.
Global agriculture company selling seeds (Pioneer brand) and crop-protection chemicals to farmers, spun off from DowDuPont.
Farmers buy new seed each season because hybrid and patented traits cannot be replanted, so seed is a repeat annual sale priced on the yield it delivers, while crop-protection chemicals are sold through retailers on a more commodity-like basis. Seed is the larger and steadier business. Spun out of DowDuPont in 2019, it announced in 2025 a plan to split seed and crop protection into two companies.
Moat: narrow (IP / patents, brand, distribution). Patented germplasm/traits and an established farmer-facing brand and dealer network support pricing.
Headquarters: Indianapolis, Indiana, US · Founded: 2019 · Employees: 21,500
Size Corteva (CTVA) is a United States Materials company (Agricultural Commodities/Milling) with a market value of $7.94B, the 892nd largest of 3,117 United States companies the cockpit tracks. Shares closed at $11.90 on 6 Nov 2026.
Performance Over six months the shares fell 85.3%, against -7.5% for the median peer and -1.1% for the United States market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 3.7% over the last twelve months (peer median +9.6%); the operating margin is 16.7% (peer median 13.7%).
Valuation It trades at 30.4× forward earnings against a peer median of 10.6× (3rd most expensive of 20).
Price implies For today's price to make sense, revenue must grow about -17% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is -21 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 1.5 points above its cost of capital (6.9% WACC).
Backlog Backlog (remaining performance obligations) was $155M at 30 Jun 2026, up 10% on a year earlier — 0.0 years of trailing revenue. Backlog detail →
Short interest Short interest is 5.8% of the free float (15 Oct 2026).
Next results Next results expected around 11 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $17.8B | $17.4B | $16.9B | $17.2B | $17.5B |
| Revenue growth | — | +3% | -2% | -1% | — |
| Gross profit | $8.09B | $7.75B | $6.67B | $6.63B | $6.28B |
| EBITDA | $4.21B | $3.99B | $3.29B | $3.33B | $3.12B |
| Net income | $1.01B | $1.09B | $907M | $735M | $1.15B |
| Free cash flow | $629M | $2.81B | $1.55B | $1.17B | $267M |
| Capital expenditure | $582M | $591M | $597M | $595M | $605M |
| Total debt | $4.88B | $3.00B | $3.18B | $2.98B | $1.76B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Corteva CTVA | $7.94B | -85% | +4% | 17% | 30.4× | -16.6% |
| Bayer BAYN.DE | $61.2B | +46% | -2% | 14% | 12.3× | 2.1% |
| Basf BAS.DE | $52.6B | +2% | -4% | 7% | 16.8× | 5.7% |
| FMC FMC | $876M | -58% | -22% | -21% | 6.2× | -2.8% |
| Nutrien NTR.TO | $34.3B | +8% | +8% | 14% | 13.2× | 4.1% |
Peer set: Sector in the same market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CTVA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -13.4% | -3.9% | 4th lowest of 21 |
| 6-month return | -85.3% | -7.5% | lowest of 21 |
| Distance from 52-week high | -86.9% | -29.4% | lowest of 21 |
| Revenue growth (TTM) | +3.7% | +9.6% | 9th lowest of 21 |
| Operating margin | 16.7% | 13.7% | 9th highest of 21 |
| Forward P/E | 30.4× | 10.6× | 3rd most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | -16.6% | 4.0% | least demanding of 15 |
| Growth delivered (Del g) | +4.1% | +7.2% | 3rd lowest of 15 |
| Hurdle (Req g minus delivered) | -20.7 pp | -3.1 pp | 4th least demanding of 15 |
| ROIC minus cost of capital | +1.5 pp | +2.3 pp | 10th lowest of 21 |
| EV / EBITDA | 2.5× | 7.9× | 2nd cheapest of 19 |
| Net debt / EBITDA | 0.5× | 1.4× | 8th least indebted of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Corteva CTVA | United States | $7.94B | -85% | +4% | 17% | 30.4× | -16.6% | +4.1% |
| Axalta Coating Systems AXTA | United States | $7.80B | +25% | 0% | 14% | 14.0× | 8.3% | +6.5% |
| Westlake WLK | United States | $8.11B | -32% | 0% | 1% | 38.6× | 37.4% | +8.3% |
| Element Solutions ESI | United States | $7.61B | -29% | +40% | 14% | 15.0× | 16.6% | +6.6% |
| Gerdau S.A. Pfd Sponsored ADR Repr 1 Pfd Sh GGB | United States | $8.41B | -10% | +10% | 9% | 7.9× | 2.3% | +8.0% |
| Eastman Chemical EMN | United States | $7.37B | -13% | 0% | 10% | 10.2× | 5.1% | +0.7% |
| Compania de Minas Buenaventura SAA Sponsored ADR BVN | United States | $7.25B | -21% | +64% | 45% | 6.5× | -14.1% | +20.7% |
| Mosaic Company (The) MOS | United States | $7.11B | +2% | 0% | 3% | 26.2× | n/a | n/a |
| AptarGroup ATR | United States | $9.03B | +18% | +9% | 12% | 23.4× | 4.3% | +5.2% |
| Commercial Metals CMC | United States | $6.85B | -12% | +20% | 9% | 9.3× | 6.2% | +6.9% |
| Solstice Advanced Materials SOLS | United States | $9.22B | -26% | +3% | 17% | 17.8× | 0.3% | +2.7% |
| Owens Corning OC | United States | $9.59B | 0% | -11% | 14% | 15.3× | 3.6% | +7.4% |
| Cleveland-Cliffs CLF | United States | $6.54B | +4% | +8% | -1% | 6.6× | n/a | n/a |
| Ternium S.A. Sponsored ADR TX | United States | $9.65B | +5% | -1% | 8% | 6.7× | n/a | n/a |
| Aura Minerals AUGO | United States | $6.52B | -5% | +89% | 53% | 10.6× | -6.0% | +25.2% |
| Harmony Gold Mining Co. Ltd. Sponsored ADR HMY | United States | $9.84B | -3% | +50% | 45% | 5.3× | -14.1% | +17.7% |
| NewMarket NEU | United States | $6.39B | +1% | +1% | 20% | n/a | -0.8% | +6.3% |
| Hecla Mining HL | United States | $9.90B | -21% | +30% | 48% | 18.1× | 8.0% | +15.0% |
| MP Materials MP | United States | $6.31B | -47% | +72% | -17% | 248.7× | n/a | n/a |
| Sibanye Stillwater Limited Sponsored ADR SBSW | United States | $6.30B | -29% | +59% | 26% | 5.9× | n/a | n/a |
| Sasol Limited Sponsored ADR SSL | United States | $10.3B | +14% | +18% | 22% | 4.8× | n/a | n/a |
Corteva reported $155M of remaining performance obligations at 30 Jun 2026, up 10% from a year earlier and up 5% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.